In this one-hour webinar hosted by NURA, Randolph Ashton, PhD, Co-Founder and CEO of Neurosetta, will present on the RosetteArray® platform which enables quantitative high-throughput screening of human developmental neurotoxicity (DNT) for chemical risk assessment.

Additional information can be found at: https://www.PCRM.org/NURATraining

Registration: https://us06web.zoom.us/webinar/register/8117249481523/WN_17rnPgHGTp2oBmfswq5REg